Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB00274ApprovedSmall molecule
Cefmetazole is a cephalosporin antibiotic used to treat a variety of bacterial infections. A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms.
- Mechanism
- Curator reviewed
The bactericidal activity of cefmetazole results from the inhibition of cell wall synthesis via affinity for penicillin-binding proteins (PBPs).
- Primary indication
- For the treatment of infections caused by susceptible organisms.Curator reviewed · 1 structured indication
- Formula / weight
- C15H17N7O5S3 · 471.534 g/mol (avg)
- Code names
- U-72791
Resolves to
Clinical / RWD
Structure
InChIKey
SNBUBQHDYVFSQF-HIFRSBDPSA-NSMILES[H][C@]12SCC(CSC3=NN=NN3C)=C(N1C(=O)[C@]2(NC(=O)CSCC#N)OC)C(O)=OTransporters
What you can answer from here — as of September 23, 2026
7Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Cefmetazole, and which of those have an active Phase 3 trial?